28th September 2016, London: Clintec International (Clintec) is celebrating being awarded Scale-Up Business of the Year, with founder and CEO Dr Rabinder Buttar also honoured as a finalist for Entrepreneur of the Year at the 5th Minority Supplier Development Network UK’s (MSDUK) awards ceremony.
This glamorous event was hosted by renowned British television comedian and playwright Meera Syal, with Paralympics presenter and wheelchair basketball player Ade Adepitan giving the keynote speech. This was attended by top pharmaceutical organisations GlaxoSmithKline, Bristol Myers Squibb, Merck Sharp & Dohme and other diverse organisations, including IBM and Coca-Cola.
Theresa Harrison from Ernst and Young the award sponsor and Meera Syal presented the award to Dr Rabinder Buttar and the Clintec team. From left to right: Meera Syal, Alastair MacDonald, Dr Rabinder Buttar, Dr Robert Reekie, David Bruce, Julie Barr, Will Jackson and Theresa Harrison.
The Scale-Up Business of the Year award, sponsored by Ernst and Young, recognises Clintec’s dynamic and entrepreneurial emergence on to the global stage as a Clinical Research Organisation (CRO) and Functional Service Provider (FSP). Earlier at the MSDUK annual conference, Dr Buttar took part in a panel discussion, sponsored by Coca-Cola, on how to Scale-Up a business.
A multi-award winning and woman-majority owned full-service CRO which embraces diversity, Clintec was formed nearly 20 years ago by its CEO and Chairman, Dr Rabinder Buttar. With capabilities in over 80 countries, Clintec delivers innovative, customised clinical research solutions and talented functional services to the clinical development sector in a fast, flexible and focused way. Clintec provides services to seven of the world’s top 10 pharmaceutical companies, leading mid-market biopharmaceutical organisations, as well as small and medium-sized biotechnology companies. Clintec’s entrepreneurial solutions stem from the organisation’s focus on delivering not only what the customers require now, but what they will require to meet industry challenges in the future.
MSDUK, which is celebrating its own 10 year anniversary, seeks to recognise purchasing organisations and the hugely talented and entrepreneurial ethnic minority businesses in the UK for their collaborative efforts to make supply chains both inclusive and competitive. MSDUK was founded by businessman Mayank Shah, CEO, in 2006 as a vehicle to assist the very entrepreneurial ethnic minority business community to realise their ambitions. During his keynote speech Ade Adepitan shared the inspiring experience of his dreams finally coming true following his attendance at the Paralympics in Rio. He congratulated everyone at the event and MSDUK for the difference they are making in our society and encouraged all in his assertion that ‘One day people will respect us’. Pictured right: Ade Adepitan with Dr Rabinder Buttar
Dr Buttar said,
“I am thrilled to accept this prestigious award on behalf of Clintec International in recognition of our ongoing expansion both in service lines and in geographical reach. As founder of the organisation, I have always believed that further success comes from the early recognition not only of what our clients want today, but also will want in the future, and then having the courage to build my company along those lines with the support of my team. Embracing diversity has always been a core pillar of Clintec in building and developing a global team of experts in clinical research. This award endorses that approach and also recognises the major contributions made by Clintec’s management team and staff in building for our future success. This endorsement puts our achievements on the map and enhances our reputation with current and future clients.”
Under Dr Buttar’s visionary leadership, Clintec has organically evolved into a renowned global player within the clinical research outsourcing arena and is the most geographically diverse mid-market CRO in the world, with an operating platform on a par with its multi-billion dollar competitors. Clintec’s success lies in a twofold approach, providing flexible, bespoke solutions which meet its client’s needs, whilst at the same time creating an excellent working environment that supports and nurtures its staff.
In addition to driving business growth, Dr Buttar has established the Academy of Clinical Research Excellence and unique graduate programmes across multiple regions to provide continuous development opportunities for staff and attracting new talent into the clinical research sector. In 2015 Dr Buttar was admitted into Strathclyde University’s Academy of Distinguished Entrepreneurs for her work in establishing and developing Clintec and was previously named a top 10 practising entrepreneurial scientist in Britain by the British Science Council.